Notices served but no violation yet

Indian cricketers Yashasvi Jaiswal and Shafali Verma have been served official “missed test” notices by the National Anti-Doping Agency (NADA). The agency issued the notices after both players were reportedly not available at their declared locations for out-of-competition dope tests.

The Board of Control for Cricket in India (BCCI) has also been informed. Both cricketers are part of NADA’s Registered Testing Pool (RTP), which requires them to regularly update their whereabouts for surprise sample collection.

At this stage, this is not an anti-doping violation. But the development has drawn attention because repeated failures can lead to disciplinary action under NADA’s code.

What happened with Jaiswal and Shafali?

According to a India Today report, NADA officials attempted to test Jaiswal on December 17 last year. Shafali’s scheduled test was on November 7. On both occasions, the players were not found at the locations they had submitted to the agency.

NADA later asked both to explain the situation. Jaiswal reportedly received the communication on February 18, while Shafali got hers on February 20. No response came within the given time, so the agency recorded their first missed tests.

Under NADA rules, athletes in the RTP must provide a specific time slot and exact location where a Doping Control Officer can reach them for surprise testing — even during off-season or personal breaks.

Three failures within a year can bring suspension

A single missed test does not automatically mean a rule violation. But three whereabouts failures within 12 months can be treated as an anti-doping violation. If a player fails to defend themselves before NADA’s hearing panel, they could face a suspension of up to two years.

The system is designed to ensure athletes remain available for random testing at all times — outside tournaments, training camps, or personal travel.

Crucial time for both cricketers

The notices have come at an important stage in their careers. Jaiswal is currently playing for Rajasthan Royals in IPL 2026. The team is still fighting for a playoff spot, and any distraction is unwelcome.

Shafali remains a key part of India Women’s plans ahead of the Women’s T20 World Cup in England and Wales, starting June 12. Missing tests at this stage, even procedural ones, adds unwanted attention.

A reminder of past doping cases

The incident has reminded many of Prithvi Shaw’s 2019 case. The former India opener received an eight-month suspension after testing positive for Terbutaline, a banned substance found in cough syrup. The BCCI had then clarified Shaw consumed it unintentionally.

Unlike that case, the current notices to Jaiswal and Shafali are only about missed tests — not failed samples. Still, the warnings underline how seriously NADA enforces compliance for modern athletes. Both players now have a chance to respond or update their whereabouts more carefully to avoid further notices.